Talazoparib
Talazoparib
Latest Posts
-
Neoadjuant PARP inhibitor treatment shrinks tumors in BRCA-positive breast cancer patients
All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of Texas MD Anderson…
You must be logged in to post a comment.